Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry
19/03/2024
Calvo-Gutiérrez, J., López-Medina, C., Otero-Varela, L., Escudero-Contreras, A., Ortega-Castro, R., Ladehesa-Pineda, L., ... & Castrejón, I.
Arthritis Research & Therapy
https://doi.org/10.1186/s13075-024-03287-9
doi: 10.1186/s13075-024-03287-9